Supernus Pharmaceuticals Gross Margin 2011-2024 | SUPN

Supernus Pharmaceuticals gross margin from 2011 to 2024. Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Supernus Pharmaceuticals Gross Margin 2011-2024 | SUPN

Supernus Pharmaceuticals gross margin from 2011 to 2024. Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
Dr Reddy's Laboratories (RDY)$11.9B
BridgeBio Pharma (BBIO)$4.4B
Bausch Health Cos (BHC)$2.9B
Amphastar Pharmaceuticals (AMPH)$2.2B
Taysha Gene Therapies (TSHA)$506M
Personalis (PSNL)$245M
Assembly Biosciences (ASMB)$96M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M